Gaucher Disease News and Research

RSS
Genzyme receives Japanese marketing approval for Elaprase

Genzyme receives Japanese marketing approval for Elaprase

Researchers question genetic screening programs

Researchers question genetic screening programs

Study examines implications of genetic screening for disease that can be less serious, treatable

Study examines implications of genetic screening for disease that can be less serious, treatable

Novel preclinical gene therapy approach for treating Niemann-Pick disease

Novel preclinical gene therapy approach for treating Niemann-Pick disease

Protalix BioTherapeutics receives FDA approval to initiate a phase III trial of prGCD

Protalix BioTherapeutics receives FDA approval to initiate a phase III trial of prGCD

FDA needs authority to approve generic biologics

FDA needs authority to approve generic biologics

New genetic clues to dementia with Lewy bodies

New genetic clues to dementia with Lewy bodies

Genzyme files Glucocerebrosidase patent infringement

Genzyme files Glucocerebrosidase patent infringement

Clinical trial of enzyme replacement therapy for the treatment of Gaucher disease

Clinical trial of enzyme replacement therapy for the treatment of Gaucher disease